144 related articles for article (PubMed ID: 1330379)
1. Investigation of adrenal function in women with oligomenorrhoea and hirsutism (clinical PCOS) from the north-east of England using an adrenal stimulation test.
Turner EI; Watson MJ; Perry LA; White MC
Clin Endocrinol (Oxf); 1992 Apr; 36(4):389-97. PubMed ID: 1330379
[TBL] [Abstract][Full Text] [Related]
2. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
Colak R; Keleştimur F; Unlühizarci K; Bayram F; Sahin Y; Tutuş A
Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
[TBL] [Abstract][Full Text] [Related]
3. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
Pang SY; Lerner AJ; Stoner E; Levine LS; Oberfield SE; Engel I; New MI
J Clin Endocrinol Metab; 1985 Mar; 60(3):428-39. PubMed ID: 2982896
[TBL] [Abstract][Full Text] [Related]
4. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.
Lucky AW; Rosenfield RL; McGuire J; Rudy S; Helke J
J Clin Endocrinol Metab; 1986 May; 62(5):840-8. PubMed ID: 3007557
[TBL] [Abstract][Full Text] [Related]
5. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of late-onset adrenal 3 beta-ol-hydroxysteroid dehydrogenase deficiency in patients with hirsutism and polycystic ovaries.
Morán C; Tena G; Herrera J; Bermúdez JA; Zárate A
Arch Med Res; 1994; 25(3):315-20. PubMed ID: 7803981
[TBL] [Abstract][Full Text] [Related]
7. Evidence for heterogeneous etiologies of adrenal dysfunction in polycystic ovary syndrome.
Gonzalez F; Chang L; Horab T; Lobo RA
Fertil Steril; 1996 Sep; 66(3):354-61. PubMed ID: 8751729
[TBL] [Abstract][Full Text] [Related]
8. The frequency of late-onset 21-hydroxylase and 11 beta-hydroxylase deficiency in women with polycystic ovary syndrome.
Sahin Y; Keleştimur F
Eur J Endocrinol; 1997 Dec; 137(6):670-4. PubMed ID: 9437235
[TBL] [Abstract][Full Text] [Related]
9. Late-onset congenital adrenal hyperplasia in women with hirsutism.
Arnaout MA
Eur J Clin Invest; 1992 Oct; 22(10):651-8. PubMed ID: 1333959
[TBL] [Abstract][Full Text] [Related]
10. 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism.
Azziz R; Bradley EL; Potter HD; Boots LR
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):889-95. PubMed ID: 8456898
[TBL] [Abstract][Full Text] [Related]
11. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
Siegel SF; Finegold DN; Lanes R; Lee PA
N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515
[TBL] [Abstract][Full Text] [Related]
12. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
Moran C; Reyna R; Boots LS; Azziz R
Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
[TBL] [Abstract][Full Text] [Related]
13. Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test.
Pang S; Carbunaru G; Haider A; Copeland KC; Chang YT; Lutfallah C; Mason JI
Clin Endocrinol (Oxf); 2003 Mar; 58(3):323-31. PubMed ID: 12608938
[TBL] [Abstract][Full Text] [Related]
14. The adrenal cortex and virilization.
McKenna TJ; Cunningham SK; Loughlin T
Clin Endocrinol Metab; 1985 Nov; 14(4):997-1020. PubMed ID: 3002682
[TBL] [Abstract][Full Text] [Related]
15. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
[TBL] [Abstract][Full Text] [Related]
16. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
17. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
White D; Leigh A; Wilson C; Donaldson A; Franks S
Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
[TBL] [Abstract][Full Text] [Related]
18. Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome.
Gonzalez F; Chang L; Horab T; Stanczyk FZ; Crickard K; Lobo RA
Fertil Steril; 1999 Mar; 71(3):439-44. PubMed ID: 10065779
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the relationship between insulin resistance and the activity of steroid C17,20-lyase and 3beta-hydroxysteroid dehydrogenase in ovaries and adrenals in women with polycystic ovary syndrome.
Vrbíklová J; Hill M; Stárka L; Vondra K; Sulcová J; Snajderová M; Cibula D; Pobisová Z; Bendlová B
Exp Clin Endocrinol Diabetes; 2000; 108(7):455-62. PubMed ID: 11083066
[TBL] [Abstract][Full Text] [Related]
20. Alternate pathway 17,20-lyase enzyme activity in the adrenals is enhanced in patients with polycystic ovary syndrome.
Keleştimur F; Sahin Y
Fertil Steril; 1999 Jun; 71(6):1075-8. PubMed ID: 10360913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
